760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
ID: 36C77025Q0079Type: Solicitation
AwardedDec 31, 2024
$725.5K$725,474
AwardeePharmacy Buying Association, Inc. Kansas City MO 64120 USA
Award #:36C77025P0062
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/1dcd63267b5641e99c0c9388ce147548/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.

    Point(s) of Contact
    Jennifer L Knight
    (913) 684-0162
    jennifer.knight@va.gov
    Files
    Title
    Posted
    S02_JnA_Q0079_allsigned.pdf
    The Department of Veterans Affairs is seeking to procure five specific brand name pharmaceuticals for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under the Simplified Acquisition Procedures outlined in FAR 13.5. The justification for sole-source procurement highlights that only the unique products can fulfill the requirements established by physician prescriptions, with no substitutions permitted due to clinical evaluations by Pharmacy Benefits Management (PBM). The procurement will be a firm-fixed-price contract, with delivery expected within ten days after receipt of order. Market research, conducted to assess available sources, confirmed that Abbvie, the original equipment manufacturer (OEM) of the specified products, does not have registered small business distributors that meet the necessary criteria under the Non-Manufacturer Rule. Consequently, competition is restricted as no other suppliers can provide the required pharmaceuticals, aligning with regulatory provisions. Although previous contracts involved both large and small businesses, only qualified vendors complying with Drug Supply Chain Security Act requirements will be solicited. The anticipated cost is expected to be fair based on historical data and market evaluations, ensuring compliance with procurement guidelines. Overall, this acquisition underlines the VA's commitment to providing specific medications to veterans while adhering to regulatory and market procedures.
    S02_Pre_Sol_36C77025Q0079_final_.pdf
    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of Armour Thyroid tablets for the Leavenworth CMOP facility, located at 5000 S. 13th Street, Leavenworth, Kansas. The solicitation number for this request is 36C77025Q0079, with bids due by December 27, 2024, at 4 PM Central Time. This contract is classified under the product service code 6505 (Drug and Biologicals) and the NAICS code 325412 (Pharmaceutical Preparation Manufacturing). A total of five different Armour Thyroid tablet variants, ranging from 30-180mg, are required in specific quantities and packaging configurations. Vendors must be registered in SAM.gov and submit their proposals via email, including essential documentation such as the signed SF1449 solicitation cover page, pricing schedule, applicable licenses, and a Buy American Act Certificate if necessary. Timely and compliant submissions are critical, as incomplete packages will be rejected. This effort underscores the VA’s commitment to ensuring a stable supply of essential medications for veterans' care while promoting compliance with federal regulations.
    S02_Pricing Schedule_Q0079.xlsx
    The document pertains to a Request for Quotation (RFQ) for pharmaceutical supplies from the Leavenworth CMOP, with a specific focus on the procurement of various dosages of Armour Thyroid tablets. The RFQ identifies necessary documentation, including a signed solicitation cover page (SF1449), a quote spreadsheet, and compliance with the Buy American Act (BAA). Vendors must submit their quotes by December 27, 2024, by 4:00 PM CST, with a requirement for only one submission per vendor. Key products listed include multiple strengths of Armour Thyroid tablets, with specific quantities requested. Each submission must detail unit pricing, total pricing, and product expiration dates, ensuring a minimum shelf life of one year from delivery. Additional requirements include a state wholesale distributor license, and if applicable, a subcontracting plan. This RFQ reflects government efforts to secure essential pharmaceuticals, ensuring compliance with federal regulations and prioritizing quality supply chains for healthcare provisions. Overall, it serves the objective of facilitating a streamlined procurement process while adhering to regulatory stipulations.
    S02_RFQ_36C77025Q0079_.pdf
    The document outlines a federal Request for Proposal (RFP) from the Department of Veterans Affairs (VA), specifically for the acquisition of pharmaceutical products for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP). It specifies that the solicitation (number 36C77025Q0079) is open to all businesses, but emphasizes a goal for small business participation. The RFP includes instructions for submissions, including the requirement for a signed Standard Form 1449 and an Excel pricing schedule. Key components of the RFP involve detailing the specific pharmaceutical items requested, delivery schedules, and adherence to labeling standards such as bar coding requirements compliant with industry regulations. Additionally, it establishes conditions regarding recalls, product quality, and compliance with the Drug Supply Chain Security Act. The RFP is meticulously structured, including sections on general terms and conditions, price/cost schedules, and delivery expectations. The document stresses the importance of compliance with various federal regulations, including FAR and VAAR clauses. This procurement process exemplifies the government's commitment to sourcing pharmaceutical supplies while promoting transparency, process adherence, and support for small businesses within the federal contracting framework.
    Similar Opportunities
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for pharmaceutical agents to be included in the Uniform Formulary (UF) as part of a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) for Military Treatment Facilities (MTFs) and TRICARE pharmacies. This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of drugs, which will be evaluated by the Pharmacy and Therapeutics (P&T) Committee. Key drugs under consideration include newly approved agents for lung cancer, antihypertensive agents, oncological agents, diuretics, antilipidemics, and targeted immunomodulatory biologics, with quotes due by January 5, 2026, for a committee meeting scheduled for February 4-5, 2026. Interested manufacturers should contact Tracy Banks or Julia Trang via email for further details and ensure compliance with submission requirements outlined in the RFQ document HT9402-26-Q-9103.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.
    8105--760-26-1-060-0080 -Leavenworth CMOP SHAWNEE MAILERS (VA-26-00026100)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking quotations from qualified Service-Disabled Veteran-Owned Small Businesses (SDVOSB) for the procurement of two types of mailers to be delivered to the VA CMOP facility in Shawnee, Kansas. The specific requirements include the Sprint Sidepouch mailer (13x11.5, 2.5 mil) and the AutoBag 550 mailer (12x14, 2.5 mil), with delivery to be split into two equal shipments. These mailers are essential for the operations of the VA's Consolidated Mail Outpatient Pharmacy (CMOP), which plays a critical role in providing medications to veterans. Interested vendors must submit their quotations, including a signed SF1449, price schedule, OEM documentation, and a Buy American Act Certificate, to Kelley Cunningham at kelley.cunningham@va.gov by December 22, 2025, to be considered for this opportunity.